Analysis of T cell receptor AV and BV chain gene expression by infiltrating lymphocytes in Spitz naevi and in halo naevi

Melanoma Research

Volumn 7, Issue 1, 1997, Pages 49-57

  Birck, A ^a,b   Thor Straten, P ^a   Li, L ^a   Hou Jensen, K ^b   Sugar J ^c   Zeuthen, J ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b Mental Health Services CPH   (Denmark)

^c NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

halo naevi; malignant melanoma; oligoclonality; RC PCR; Spitz naevi; T cell receptor variable gene repertoire; tumour infiltrating lymphocytes

Indexed keywords

HLA ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR;

ARTICLE; CELL CLONE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; PIGMENTED NEVUS; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; CLONING, MOLECULAR; FEMALE; GENE EXPRESSION; HLA ANTIGENS; HUMANS; MALE; MELANOCYTES; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEVUS, EPITHELIOID AND SPINDLE CELL; NEVUS, PIGMENTED; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES;

EID: 0031050951     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199702000-00008     Document Type: Article

References (34)

1. Whiteside TL, Parmiani G. Tumour-infiltrating lymphocytes: their phenotype, functions and clinical use. Cancer Immunol Immunother 1994; 39: 15-21.
2. Itoh K, Platsoucas CD, Balch CM. Autologous tumour-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. J Exp Med 1988; 168: 1419-1441.
3. Clark WH. Tumour progression and the nature of cancer, Br J Cancer 1991; 64: 631-644.
4. Ferradini L, Mackensen A, Geneveé C, et al. Analysis of T cell receptor variability in tumour-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion. J Clin Invest 1993; 91: 1183-1190.
5. Mackensen A, Ferradini L, Carcelain G, et al. Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumour activity in a human regressive melanoma. Cancer Res 1993; 53: 3569-3573.
6. thor Straten P, Schøller J, Hou-Hensen K, et al. Preferential usage of T-cell receptor αβ variable regions among tumourinfiltrating lymphocytes in primary human malignant melanomas. Int J Cancer 1994; 56: 78-86.
7. Nitta T, Oksenberg JK, Rao NA, et al. Predominant expression of T cell receptor Vα7 in tumour-infiltrating lymphocytes of uveal melanoma. Science 1990; 249: 672-674.
8. Schøller J, thor Straten P, Birck A, et al. Analysis of T cell receptor αβ variability in lymphocytes infiltrating melanoma primary tumours and metastatic lesions. Cancer Immunol Immunother 1994; 39: 239-248.
9. Sensi M. Salva S, Castelli C, et al. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumour-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone. J Exp Med 1993; 178: 1231-1246.
10. Morita T, Salmeron MA, Moser RP, et al. Oligoclonal expansion of V beta 8 + cells in interleukin-2-activated T cells residing in subcutaneous metastatic melanoma. Clin Exp Metastasis 1992; 10: 69-76.
11. Salvi S, Segalla F, Rao S, et al. Overexpression of the T cell receptor β-chain variable region TCRBV14 in HLA-A2 matched primary human melanoma. Cancer Res 1995; 55: 3374-3379.
12. Mackensen A. Carcelain G, Viel S, et al. Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J Clin Invest 1994; 93: 1397-1402.
13. Spitz S. Melanomas of childhood. Am J Pathol 1948; 24: 591-609.
14. Binder SW, Asnong C, Paul E., et al. The histology and differential diagnosis of Spitz naevus. Sem Diagn Pathol 1993; 10: 36-46.
15. Barnhill RL, Mihm MC Jr. Histopathology of malignant melanoma and its percursor lesions. In: Balch CM, Houghton AN, Milton GW, et al. eds. Cutaneous Melanoma Philadelphia: J.B. Lippincott. 1992; 234-263.
16. Cochran AJ, Bailly C, Paul E, et al. Naevi, other than dysplastic and Spitz naevi. Sem Diagn Pathol 1993; 10: 3-17.
17. Kirkin A, Petersen TR, Olsen AC, Li L. et al. Generation of human-melanoma-specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines. Cancer Immunol Immunother 1995; 41: 71-81.
18. Browning MJ, Krausa P, Rowan A, et al. Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumour cell lines. Proc Natl Acad Sci USA 1994; 90: 2842-2845.
19. Wilson R, Lai E, Concannon P, et al. Structure, organisation and polymorphism of murine and human T cell receptor α and β chain gene families. Immunol Rev 1988; 101: 149-172.
20. Albretson C, Haukanes B-I, Aasland R, et al. Optimal conditions for hybridization with oligonucleotides: a study with the myc-oncogene DNA probes. Anal Biochem 1988; 170: 193-202.
21. Johnston RF, Pickett SC, Barker DL. Autoradiography using storage phosphor technology. Electrophoresis 1990; 11: 355-360.
22. Maize JC, Ackerman AB. Pigmented Lesions of the Skin. Philadelphia: Lea & Feibiger, 1987.
23. Burnet FM. The concept of immunological surveillance. Progr Exp Tumour Res 1970; 13: 1-27.
24. van der Bruggen P, Traversari C, Chomez P, et al. A gene encloding and antigen recoganised by cytolytic T lymphocytes on a human melanoma. Science 1991; 254: 1643-1647.
25. Nalefski EA, Kasibhatla S, Rao A. Functional analysis of the antigen binding site on the T cell receptor α chain. J Exp Med 1992; 175: 1553-1563.
26. Boitel B, Ermonval M, Panina-Bordignon P, et al. Preferenctial Vβ gene usage and lack of junctional sequence conservation among human T cell receptors for a tetanus toxin-derived peptide: evidence for a dominant role of a germline-encoded V region in antigen major histocompatability complex recognition. J Exp Med 1992; 175: 765-777.
27. Sensi M, Traversari C, Radrizzani M, et al. Cytotoxic T-lympheyte clones from different patients display limited T cell receptor variable region gene usage in HLA-A2 restricted recognition of the melanoma antigen Melan-A/MART-1. Proc Natl Acad Sci USA 1995; 92: 5674-5678.
28. Dunn DA, Gadenne A-S, Simha S, et al. T-cell receptor Vβ expression in normal skin. Proc Natl Acad Sci USA 1993; 90: 1267-1271.
29. Anichini A, Maccalli C, Mortarini R, et al, Melanocytes share antigens recognised by HLA-A2 restricted cytotoxic T cell clones from melanoma patients. J Exp Med 1993; 177; 989-998.
30. Bakker ABH, Schreurs MWJ. Deboer AJ, et al. Melanocyte lineage-specific antigen gp100 is recognised by melanomaderived tumour-infiltrating lymphocytes. J Exp Med 1994: 179; 1005-1009.
31. Coulie PG, Brichard V, Van Pel A, et al. A new gene coding for a differentiation antigen recognised by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994; 180: 35-42.
32. Wang R-F, Robbins P, Kawakami Y, et al. Identification of a gene encoding a melanoma tumour antigen recognised by HLA-A31 restricted tumour-infiltrating lymphocytes. J Exp Med 1995; 181: 799-804.
33. Brichard V, Van Pel A, Wölfel T, et al. The tyrosinase gene codes for an antigen recognised by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993; 178: 489-495.
34. Adema GJ, de Boer AJ, Vogel AM, et al. Molecular characterization of the melanocyte lineage-specific antigen gp 100. J Biol Chem 1994: 269: 20126-20133.